Quantum BioPharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Quantum BioPharma Ltd. (QNTM) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents6.003.5116.9835.2617.52
Short-Term Investments1.200.760.020.160.00
Cash & Short-Term Investments7.203.5117.0035.4217.52
Accounts Receivable3.817.420.370.500.16
Inventory0.120.000.000.000.00
Other Current Assets0.040.090.160.760.57
Total Current Assets12.0511.0917.8545.9318.26
Non-Current Assets
Property, Plant & Equipment (Net)0.130.120.260.170.00
Long-Term Investments0.000.010.830.661.68
Intangible Assets4.935.3612.0416.2013.42
Other Non-Current Assets0.000.000.000.008.61
Total Non-Current Assets5.076.3920.5617.0323.71
Total Assets17.1217.4738.4162.9641.97
Current Liabilities
Accounts Payable3.254.202.763.003.70
Short-Term Debt0.150.300.300.300.00
Current Portion of Long-Term Debt0.150.000.000.000.00
Accrued Liabilities1.110.954.354.411.62
Deferred Revenue1.000.000.000.000.00
Other Current Liabilities0.490.030.240.771.60
Total Current Liabilities6.684.577.838.705.73
Non-Current Liabilities
Long-Term Debt0.000.000.040.130.08
Other Non-Current Liabilities0.000.000.000.000.21
Total Non-Current Liabilities0.000.000.040.130.29
Total Liabilities6.684.577.878.836.02
Stockholders' Equity
Common Stock150.47137.78143.41152.32103.21
Retained Earnings-172.11-157.91-144.16-126.15-90.87
Accumulated Other Comprehensive Income2.050.420.650.245.18
Additional Paid-in Capital31.0732.9528.5022.5818.79
Minority Interest-1.04-0.330.000.000.00
Shares Outstanding2.300.610.590.620.00
Total Stockholders' Equity10.4412.9130.5454.13-67.11
Total Liabilities & Equity17.1217.4738.4162.9641.97